Japan Market Entry & Growth for MedTech & Pharma. Simplified.

D.D.S.-led strategy delivering: Strategic Talent. Clinical Adoption. Commercial Traction.

Book Your Strategy Call

Let's build your growth strategy together.

Our Core Strategic Pillars

The impact we create spans entire organizations, but always starts with people.

1. Strategic Talent

2. Clinical Adoption

3. Commercial Traction

Core Offerings / Deliverables

• Executive Search: Securing foundational leaders.
• KOL Advisory Board: Building your clinical credibility.
• Commercial Team Structuring: Designing the optimal sales and marketing org chart.

• Channel Strategy Blueprint: A clear analysis and recommendation for your distributor vs. direct-to-market approach.
• Commercial Launch Playbook: A step-by-step plan for market access, reimbursement, and sales execution.
• Growth & Turnaround Audit: A diagnostic review to identify the root cause of revenue plateaus and team underperformance.

Pillar

who is it for

Entrants & Scalers

• KOL Discovery & Mapping Sprint: A focused project to identify and profile the top clinical influencers for your tech.
• Clinical Market Validation: D.D.S.-led assessment of your product-market fit with local practitioners.
• Regulatory Pathway Advisory: Strategic guidance on navigating the PMDA landscape.

Primarily Entrants

Primarily Scalers

We Partner with Ambitious MedTech & pharma Leaders

With Japan's healthcare spending exceeding 11% of its GDP and a rapidly aging population driving sustained demand, the opportunity for innovation in MedTech and BioPharma has never been greater. We provide the strategic guidance and on-the-ground talent to help you capture it.

Our partners are global innovators who recognize the unique clinical and commercial complexities of the Japanese market. We typically support them at two key stages:

1. Market Entrants

You are preparing to enter Japan, or a new clinical segment within it. Your primary challenge is de-risking the investment by finding the right foundational strategy and leadership. We help you replace uncertainty with an actionable plan to:

Secure your first "boots-on-the-ground" leaders (Sales, Marketing, Clinical, RA/QA).
Discover and engage your first Key Opinion Leaders (KOLs).
Navigate the PMDA regulatory pathway.
Define the optimal channel strategy (distributor vs. direct).

2. In-Market Scalers

You are already operating in Japan but are facing a growth plateau, launching a critical new product, or dealing with the aftermath of bad hires and high turnover. We help you diagnose the issues and rebuild momentum to:

Drive a successful commercial launch for a newly approved flagship product.
Break through revenue plateaus by revitalizing a passive commercial organization.
Rebuild and up-skill your leadership team (Head of Medical Affairs, Market Access, Head of Sales, Marketing, Medical Education, Clinical Training).
Mitigate "damage control" situations and restore market confidence.

Our Areas of Deep Expertise

Regenerative Medicine (Biopharma & MedTech)
Digital Dentistry & Imaging
Diagnostics & IVD
Medical Aesthetics & Dermatology

Driving growth for Global Innovators

Dental, Regen Med, Med Aesthetics

Straumann
Nobel Biocare
Dentsply Sirona
Align Technology
Geistlich Pharma
ZO Skin Health
Establishment Labs
Milteny Biotec
Sony Biotechnology
Leica Biosystems
Kimberly Clark HC
UCB Japan

What Our Partners Are Saying…

"Re-entering Japan after a difficult distributor partnership felt like starting from zero. We had no team and a stalled growth trajectory in our second-largest market. Inoventic didn't just find candidates; they served as our strategic partner, building our entire commercial and operational team from the ground up. They understood our uniquely complex talent needs and delivered the 10 leaders who turned our business around, allowing us to hit our ambitious scale-up targets."

— SVP, Global Aesthetics Company

Scientific & Diagnostics

Illumina
Thermo Fisher Scientific
Bio-Rad Laboratories
Qiagen
Beckman Coulter
Sysmex
Hologic
Bruker
AB Sciex
Nova Biomedical
Mettler Toledo

Broader MedTech & Pharma Ecosystem

Merck
Teva Takeda Pharma
LONZA
Almac
Covance
EPS
Hitachi Hi-Tech
IDEXX Laboratories
Eurofins Genomics
FOSS
Catalent
A.D.A.M. Innovations

"We chose Japan as the global launchpad for our game-changing new technology, which came with immense investor pressure and zero room for error. The standard commercial profile wasn't a fit for our sensitive category. Inoventic understood this perfectly and secured the two foundational leaders—our APAC Head of Medical Education and Brand Manager—who were instrumental in our success. Their work directly contributed to a successful clinical launch, positive KOL engagement, and a significant increase in our stock price."

— CEO, US-Based FemTech Innovator

"We were at a critical inflection point, facing immense investor pressure to transform our consumer genomics company into a regional, AI-driven data platform for a potential IPO. This required a complete overhaul of our leadership and culture. Inoventic was the strategic partner who architected our new executive dream team. They brought us the A-list leaders—our new CMO, CTO, CSO, and Heads of Comms and PR from companies like Google and Mercari—who laid the foundation to transform our business model and position us as the undisputed leader in our market."

— Board Member, APAC-based Genomics AI Company

Navigating Japan's Market is a Unique Challenge

Struggling to translate global strategy into local clinical adoption?

Concerned about the time and cost of finding the right KOLs and first hires?

Seeing slower-than-expected growth from your current team?

Your Unfair Advantage

Clinician-Led Strategy

Founded by a D.D.S. We speak the language of your customers.

20+ Years In-Market Experience

Deep networks and an unparalleled understanding of the Japan/Korea ecosystem.

Built for Speed & Impact

We deliver actionable one-page plans, not hundred-page novels.

Emilio Campos DDS

Founder of Inoventic - Japan MedTech Strategy Consultant

My entire career, from clinician to researcher to strategic advisor, has been focused on bridging the gap between brilliant technology and the complexities of the Japanese market. I founded Inoventic to be the hands-on, expert partner I wish my clients had from day one.

— Emilio Campos, D.D.S., Founder